Pliant Therapeutics
PLRX
PLRX
135 hedge funds and large institutions have $971M invested in Pliant Therapeutics in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 47 increasing their positions, 36 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
14% less call options, than puts
Call options by funds: $4.2M | Put options by funds: $4.91M
15% less capital invested
Capital invested by funds: $1.14B → $971M (-$172M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
135
Holding in Top 10
5
Calls
$4.2M
Puts
$4.91M
Top Buyers
| 1 | +$7.46M | |
| 2 | +$6.93M | |
| 3 | +$6.25M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.15M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$5.97M |
Top Sellers
| 1 | -$8.6M | |
| 2 | -$6.35M | |
| 3 | -$2.18M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$2.01M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.62M |